Jazz Pharmaceuticals PLC header image

Jazz Pharmaceuticals PLC

JAZZ

Equity

ISIN IE00B4Q5ZN47 / Valor 14769757

NASDAQ (2026-07-02)
USD 243.47+2.51%

Jazz Pharmaceuticals PLC
UMushroom community rating:

star star star star star
4.00 3 votes No rating yet
NegativeNeutralPositive

About company

Jazz Pharmaceuticals PLC is a biopharmaceutical company known for its focus on developing and commercializing innovative medicines aimed at addressing significant unmet medical needs. With a strong presence on the NASDAQ (JAZZ), the company has carved out a niche in the healthcare sector, particularly in the areas of sleep disorders, epilepsy, and oncology. Jazz Pharmaceuticals boasts a diverse portfolio of marketed medicines, with leading therapies that have made substantial impacts in their respective fields. The company's commitment to patient-focused and science-driven initiatives is evident in its robust pipeline, which is dedicated to pioneering research and development in oncology and neuroscience. Through its efforts, Jazz Pharmaceuticals aims to transform the lives of patients and their families by offering new, advanced therapeutic options.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

121%1Y
96.4%3Y
34.1%5Y

Performance

35.9%1Y
32.8%3Y
31.6%5Y

Volatility

Market cap

15276 M

Market cap (USD)

Daily traded volume (Shares)

766,982

Daily traded volume (Shares)

1 day high/low

124.03 / 122.1

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

4.00

3 votes
Performance:
starstarstarstarstar
4.00
Innovation:
starstarstarstarstar
4.67
Society:
starstarstarstarstar
4.33
Nature:
starstarstarstarstar
4.00
Eric Strauss
Switzerland, 12 Feb 2025
star star star star star
Könnte mit den Anlaufenenden Patenten, wirklich vielversprechend sein!
Admin UMushroom
Switzerland, 12 Feb 2025
star star star star star
.
Luba Schoenig
Switzerland, 12 Feb 2025
star star star star star
Jazz Pharmaceuticals reported a 14% year-over-year revenue increase in Q3 2024, driven by strong performance from Xywav, Epidiolex, and Rylaze. The company reaffirmed its 2024 total revenue guidance of 4.0-4.1 billion, supported by robust patient demand for Xywav (+17% sales growth) and Epidiolex’s

EQUITIES OF THE SAME SECTOR

Tilray Brands Inc
Tilray Brands Inc Tilray Brands Inc Valor: 42386407
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
4.29%USD 4.62
Pacira BioSciences Inc
Pacira BioSciences Inc Pacira BioSciences Inc Valor: 12338490
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.44%USD 25.39
Ironwood Pharmaceuticals Inc
Ironwood Pharmaceuticals Inc Ironwood Pharmaceuticals Inc Valor: 10773079
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
5.10%USD 4.33
Abbott India Limited
Abbott India Limited Abbott India Limited Valor: 561999
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.50%INR 25,850.45
Arvinas Inc
Arvinas Inc Arvinas Inc Valor: 43526042
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.32%USD 8.39
Rhythm Pharmaceuticals Inc
Rhythm Pharmaceuticals Inc Rhythm Pharmaceuticals Inc Valor: 25337263
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.41%USD 114.17
Catalyst Pharmaceuticals Inc
Catalyst Pharmaceuticals Inc Catalyst Pharmaceuticals Inc Valor: 2649177
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.03%USD 31.45
Astrana Health Inc
Astrana Health Inc Astrana Health Inc Valor: 28041888
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.28%USD 49.17
Amphastar Pharmaceuticals Inc
Amphastar Pharmaceuticals Inc Amphastar Pharmaceuticals Inc Valor: 24511852
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.29%USD 19.64
Schrodinger Inc
Schrodinger Inc Schrodinger Inc Valor: 51947209
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.99%USD 16.88